[PERSON]
Rodrigo Lamounier
Featured in 1 tracked story · first seen
Situations
GLP‑1 market, usage, safety & new guidance
182 clusters · 649 sources · last updated
Latest: Brazil's SUS delays rollout of GLP‑1 weight‑loss drugs
GLP‑1 receptor agonists dominate modern obesity and diabetes therapy, now reaching primary‑care, tele‑health and Medicare, with the market projected near $105 bn by 2030. Safety monitoring confirms a modest alopecia sign